Table of Contents
ISRN Pharmaceutics
Volume 2014, Article ID 391523, 13 pages
http://dx.doi.org/10.1155/2014/391523
Research Article

High-Amylose Sodium Carboxymethyl Starch Matrices: Development and Characterization of Tramadol Hydrochloride Sustained-Release Tablets for Oral Administration

Faculté de Pharmacie, Université de Montréal, P.O. Box 6128, Downtown Station, Montreal, QC, Canada H3C 3J7

Received 22 January 2014; Accepted 2 March 2014; Published 8 April 2014

Academic Editors: T. M. Bellé Bresolin, K. Goracinova, and R. Zelkó

Copyright © 2014 Teresa Nabais and Grégoire Leclair. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Kost and S. Shefer, “Chemically-modified polysaccharides for enzymatically-controlled oral drug delivery,” Biomaterials, vol. 11, no. 9, pp. 695–698, 1990. View at Publisher · View at Google Scholar · View at Scopus
  2. C. G. Biliaderis, “The structure and interactions of starch with food constituents,” Canadian Journal of Physiology and Pharmacology, vol. 69, no. 1, pp. 60–78, 1991. View at Google Scholar · View at Scopus
  3. J. M. Fang, P. A. Fowler, C. Sayers, and P. A. Williams, “The chemical modification of a range of starches under aqueous reaction conditions,” Carbohydrate Polymers, vol. 55, no. 3, pp. 283–289, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Svensson and A.-C. Eliasson, “Crystalline changes in native wheat and potato starches at intermediate water levels during gelatinization,” Carbohydrate Polymers, vol. 26, no. 3, pp. 171–176, 1995. View at Google Scholar · View at Scopus
  5. A. Rajan, V. S. Prasad, and T. Emilia Abraham, “Enzymatic esterification of starch using recovered coconut oil,” International Journal of Biological Macromolecules, vol. 39, no. 4-5, pp. 265–272, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Brouillet, G. Baylac, L. Cartilier, and B. Bataille, “High-amylose sodium carboxymethyl starch matrices for oral, sustained drug release: development of a spray-drying manufacturing process,” Drug Development and Industrial Pharmacy, vol. 36, no. 7, pp. 795–805, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Cartilier, I. Moussa, C. Chebli, and S. Buczkowski, “Substitude amylose as a matrix for sustained drug release,” U.S. Patent 5,879,707, 1999. View at Google Scholar
  8. L. Cartilier, M. Ungur, and C. Chebli, “Tablet formulation for sustained drug-release,” Canadian Patent Application 2,491,665, PCT Application no. PCT/CA2005/001934, 2005.
  9. C. Chebli and L. Cartilier, “Effect of some physical parameters on the sustained drug-release properties of substituted amylose matrices,” International Journal of Pharmaceutics, vol. 193, no. 2, pp. 167–173, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. S. H. Moghadam, H. W. Wang, E. S. El-Leithy, C. Chebli, and L. Cartilier, “Substituted amylose matrices for oral drug delivery,” Biomedical Materials, vol. 2, no. 1, article S11, pp. S71–S77, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Chebli, I. Moussa, S. Buczkowski, and L. Cartilier, “Substituted amylose as a matrix for sustained drug release,” Pharmaceutical Research, vol. 16, no. 9, pp. 1436–1440, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Ungur, N. Yonis, C. Chebli, and L. Cartilier, “The evaluation of carboxymethylamylose for oral drug delivery systems: from laboratory to pilot scale,” in Proceedings of the 3rd International Symposium on Advanced Biomaterials/Biomechanics (ISAB2 '05), vol. 271, Montreal, Canada, 2005.
  13. S. Edge and R. W. Miller, “Sodium starch glycolate,” in Handbook of Pharmaceutical Excipients, R. C. Rowe, P. J. Sheskey, and S. C. Owen, Eds., pp. 701–704, Pharmaceutical Press, London, UK, 2005. View at Google Scholar
  14. V. Lenaerts, I. Moussa, Y. Dumoulin et al., “Cross-linked high amylose starch for controlled release of drugs: recent advances,” Journal of Controlled Release, vol. 53, no. 1–3, pp. 225–234, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. F. Brouillet, B. Bataille, and L. Cartilier, “High-amylose sodium carboxymethyl starch matrices for oral, sustained drug-release: formulation aspects and in vitro drug-release evaluation,” International Journal of Pharmaceutics, vol. 356, no. 1-2, pp. 52–60, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Nabais, F. Brouillet, S. Kyriacos et al., “High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 65, no. 3, pp. 371–378, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. L. J. Scott and C. M. Perry, “Tramadol: a review of its use in perioperative pain,” Drugs, vol. 60, no. 1, pp. 139–176, 2000. View at Google Scholar · View at Scopus
  18. S. Nossol, M. Schwarzbold, and T. Stadler, “Treatment of pain with sustained-release tramadol 100, 150, 200 mg: a post-marketing surveillance study,” International Journal of Clinical Practice, vol. 52, no. 2, pp. 115–121, 1998. View at Google Scholar · View at Scopus
  19. S. Grond and A. Sablotzki, “Clinical pharmacology of tramadol,” Clinical Pharmacokinetics, vol. 43, no. 13, pp. 879–923, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. R. L. Barkin, “Extended-release tramadol (ULTRAM ER): a pharmacotherapeutic, pharmacokinetic, and pharmacodynamic focus on effectiveness and safety in patients with chronic/persistent pain,” The American Journal of Therapeutics, vol. 15, no. 2, pp. 157–166, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. P. I. Hair, M. P. Curran, and S. J. Keam, “Tramadol extended-release tablets,” Drugs, vol. 66, no. 15, pp. 2017–2027, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Malonne, B. Sonet, B. Streel et al., “Pharmacokinetic evaluation of a new oral sustained release dosage form of tramadol,” British Journal of Clinical Pharmacology, vol. 57, no. 3, pp. 270–278, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Raber, H. U. Schulz, M. Schürer, S. Krupp, and H. Momberger, “Pharmacokinetic properties of tramadol sustained release capsules: 3rd communication: investigation of relative bioavailability under steady state conditions,” Arzneimittelforschung, vol. 49, no. 7, pp. 594–598, 1999. View at Google Scholar · View at Scopus
  24. U.S. Pharmacopeial Convention, The United States Pharmacopeia 36—National Formulary 31, Rockville, Md, USA, 2013.
  25. M. Walden, F. A. Nicholls, K. J. Smith, and G. T. Tucker, “The effect of ethanol on the release of opioids from oral prolonged-release preparations,” Drug Development and Industrial Pharmacy, vol. 33, no. 10, pp. 1101–1111, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Dürig and R. Fassihi, “Evaluation of floating and sticking extended release delivery systems: an unconventional dissolution test,” Journal of Controlled Release, vol. 67, no. 1, pp. 37–44, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. J. W. Moore and H. H. Flanner, “Mathematical comparison of dissolution profiles,” Pharmaceutical Technology, vol. 20, no. 6, pp. 64–74, 1996. View at Google Scholar · View at Scopus
  28. M. Lemieux, P. Gosselin, and M. A. Mateescu, “Carboxymethyl high amylose starch as excipient for controlled drug release: mechanistic study and the influence of degree of substitution,” International Journal of Pharmaceutics, vol. 382, no. 1-2, pp. 172–182, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. N. A. Peppas and J. J. Sahlin, “A simple equation for the description of solute release. III. Coupling of diffusion and relaxation,” International Journal of Pharmaceutics, vol. 57, no. 2, pp. 169–172, 1989. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Colombo, R. Bettini, P. Santi, and N. A. Peppas, “Swellable matrices for controlled drug delivery: gel-layer behaviour, mechanisms and optimal performance,” Pharmaceutical Science and Technology Today, vol. 3, no. 6, pp. 198–204, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. B. Narasimhan and N. A. Peppas, “Molecular analysis of drug delivery systems controlled by dissolution of the polymer carrier,” Journal of Pharmaceutical Sciences, vol. 86, no. 3, pp. 297–304, 1997. View at Publisher · View at Google Scholar · View at Scopus
  32. V. V. Ranade, “Drug delivery systems 5A. Oral drug delivery,” Journal of Clinical Pharmacology, vol. 31, no. 1, pp. 2–16, 1991. View at Google Scholar · View at Scopus
  33. M. Lemieux, P. Gosselin, and M. A. Mateescu, “Influence of drying procedure and of low degree of substitution on the structural and drug release properties of carboxymethyl starch,” AAPS PharmSciTech, vol. 11, no. 2, pp. 775–785, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Calinescu, É. Nadeau, J. Mulhbacher, J. M. Fairbrother, and M.-A. Mateescu, “Carboxymethyl high amylose starch for F4 fimbriae gastro-resistant oral formulation,” International Journal of Pharmaceutics, vol. 343, no. 1-2, pp. 18–25, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. L. P. Massicotte, W. E. Baille, and M. A. Mateescu, “Carboxylated high amylose starch as pharmaceutical excipients. Structural insights and formulation of pancreatic enzymes,” International Journal of Pharmaceutics, vol. 356, no. 1-2, pp. 212–223, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. T. D. Reynolds, S. A. Mitchell, and K. M. Balwinski, “Investigation of the effect of tablet surface area/volume on drug release from hydroxypropylmethylcellulose controlled-release matrix tablets,” Drug Development and Industrial Pharmacy, vol. 28, no. 4, pp. 457–466, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Siepmann, H. Kranz, N. A. Peppas, and R. Bodmeier, “Calculation of the required size and shape of hydroxypropyl methylcellulose matrices to achieve desired drug release profiles,” International Journal of Pharmaceutics, vol. 201, no. 2, pp. 151–164, 2000. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. W. Chien, “Fundamentals of controlled drug administration,” in Novel Drug Delivery System, J. Swarbrick, Ed., pp. 465–574, Marcel Dekker, New York, NY, USA, 1982. View at Google Scholar
  39. B. Oshlack, H.-P. Huang, M. Chasin, and P. Goldenheim, “Stabilized sustained release tramadol formulations,” U.S. Patent 6,306,438 B1, 2001. View at Google Scholar
  40. W. Helbert and H. Chanzy, “Single crystals of V amylose complexed with n-butanol or n-pentanol: structural features and properties,” International Journal of Biological Macromolecules, vol. 16, no. 4, pp. 207–213, 1994. View at Publisher · View at Google Scholar · View at Scopus
  41. I. Tagarro, J. Herrera, C. Barutell et al., “Effect of a simple dose-escalation schedule on tramadol tolerability: assessment in the clinical setting,” Clinical Drug Investigation, vol. 25, no. 1, pp. 23–31, 2005. View at Publisher · View at Google Scholar · View at Scopus